GLP2-2G-XTEN: a pharmaceutical protein with improved serum half-life and efficacy in a rat Crohn's. PLoS One. 2012; 7(11): e50630

PLoS One. 2013 Jun 10;8(6):10.1371/annotation/5c7138bd-5602-466d-8daf-e75e0b7d7fdb. doi: 10.1371/annotation/5c7138bd-5602-466d-8daf-e75e0b7d7fdb. Print 2013.

Abstract

[This corrects the article on p. e50630 in vol. 7.].

Publication types

  • Corrected and Republished Article
  • Published Erratum

MeSH terms

  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacokinetics
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Crohn Disease / blood
  • Crohn Disease / drug therapy*
  • Disease Models, Animal*
  • Glucagon-Like Peptide 2 / pharmacokinetics
  • Glucagon-Like Peptide 2 / therapeutic use*
  • Half-Life
  • Indomethacin / pharmacokinetics
  • Indomethacin / therapeutic use*
  • Intestine, Small / drug effects
  • Rats
  • Recombinant Fusion Proteins / pharmacokinetics
  • Recombinant Fusion Proteins / therapeutic use*
  • Tissue Distribution

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Glucagon-Like Peptide 2
  • Recombinant Fusion Proteins
  • Indomethacin